secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001213900-23-061295
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Auditor Mayer Hoffman McCann resigns as Unicycive's independent auditor
-----------------------------------------------------------------------

- Auditor MHM resigned effective upon earlier of new auditor engagement, filing of June 2023 Form 10-Q, or Aug 20, 2023.
- No report modifications for FY 2022; no disagreements on accounting principles or audit scope during 2022 or through July 25, 2023.
- Company previously reported material weakness in internal control over financial reporting as of Dec 31, 2022 due to lack of adequate staffing.
- Company is currently interviewing other accounting firms to replace MHM as independent registered public accounting firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023061295/0001213900-23-061295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023061295/ea182586-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-061295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer